Luigi Nocera (L Nocera)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Systematic Review

Metastatic Renal Cell Carcinoma

Radical Prostatectomy

Top Venues

Prostate cancer and prostatic diseases

BJU international

The Journal of urology

This page only lists publications with an associated author ORCID identifier.

Publications

Mattia Longoni, Pietro Scilipoti, Chiara Re, Giuseppe Rosiello, Luigi Nocera, Francesco Pellegrino, Giuseppe Basile, Mario de Angelis, Leonardo Quarta, Giusy Burgio, Andrea Necchi, Antonio Cigliola, Arturo Chiti, Maria Picchio, Alessia d'Arma, Alberto Briganti, Francesco Montorsi, Marco Moschini
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients. BJU international (2024)
Mike Wenzel, Luigi Nocera, Claudia Collà Ruvolo, Christoph Würnschimmel, Zhe Tian, Shahrokh F Shariat, Fred Saad, Derya Tilki, Markus Graefen, Luis A Kluth, Alberto Briganti, Philipp Mandel, Francesco Montorsi, Felix K H Chun, Pierre I Karakiewicz
Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis. Prostate cancer and prostatic diseases (2023)
Daniele Robesti, Luigi Nocera, Federico Belladelli, Julianne G Schultz, Giuseppe Fallara, Laura Marandino, Daniele Raggi, Francesco Montorsi, Pavlos Msaouel, Andrea Necchi, Alberto Martini
The immune-related adverse events paradox in locally advanced or metastatic urothelial cancer after atezolizumab immunotherapy: Analysis of individual patient data from IMvigor210 and IMvigor211 Trials. BJU international (2023)
Giuseppe Basile, Marco Bandini, Ewan A Gibb, Jeffery S Ross, Daniele Raggi, Laura Marandino, Tiago Costa de Padua, Emanuele Crupi, Renzo Colombo, Maurizio Colecchia, Roberta Lucianò, Luigi Nocera, Marco Moschini, Alberto Briganti, Francesco Montorsi, Andrea Necchi
Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Mike Wenzel, Christoph Würnschimmel, Claudia Collà Ruvolo, Luigi Nocera, Zhe Tian, Fred Saad, Alberto Briganti, Derya Tilki, Markus Graefen, Luis A Kluth, Philipp Mandel, Felix K H Chun, Pierre I Karakiewicz
Increasing rates of NCCN high and very high-risk prostate cancer versus number of prostate biopsy cores. The Prostate 81 (12) (2021)
Mike Wenzel, Christoph Würnschimmel, Luigi Nocera, Claudia Collà Ruvolo, Zhe Tian, Shahrokh F Shariat, Fred Saad, Alberto Briganti, Markus Graefen, Luis A Kluth, Philipp Mandel, Felix K H Chun, Pierre I Karakiewicz
The effect of lymph node dissection on cancer-specific survival in salvage radical prostatectomy patients. The Prostate 81 (6) (2021)
Mike Wenzel, Claudia Collà Ruvolo, Christoph Würnschimmel, Luigi Nocera, Zhe Tian, Fred Saad, Alberto Briganti, Derya Tilki, Markus Graefen, Andreas Becker, Frederik Roos, Philipp Mandel, Felix K H Chun, Pierre I Karakiewicz
Survival rates with external beam radiation therapy in newly diagnosed elderly metastatic prostate cancer patients. The Prostate 82 (1) (2021)
Mike Wenzel, Christoph Würnschimmel, Luigi Nocera, Claudia Collà Ruvolo, Zhe Tian, Fred Saad, Alberto Briganti, Derya Tilki, Markus Graefen, Frederik C Roos, Philipp Mandel, Felix K H Chun, Pierre I Karakiewicz
The effect of primary urological cancers on survival in men with secondary prostate cancer. The Prostate 81 (15) (2021)
Mike Wenzel, Claudia Collà Ruvolo, Christoph Würnschimmel, Luigi Nocera, Pierre I Karakiewicz
Response to the letter to the editor: "Don't throw the baby out with the bath water" by Horsley et al. The Prostate 82 (3) (2021)
Luigi Nocera, Pierre I Karakiewicz, Mike Wenzel, Zhe Tian, Shahrokh F Shariat, Fred Saad, Felix K H Chun, Alberto Briganti, Anil Kapoor, Aly-Khan Lalani
Clinical Outcomes and Adverse Events after First-Line Treatment in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis. The Journal of urology 207 (1) (2021)
Mike Wenzel, Luigi Nocera, Claudia Collà Ruvolo, Christoph Würnschimmel, Zhe Tian, Shahrokh F Shariat, Fred Saad, Derya Tilki, Markus Graefen, Luis A Kluth, Alberto Briganti, Philipp Mandel, Francesco Montorsi, Felix K H Chun, Pierre I Karakiewicz
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis. Prostate cancer and prostatic diseases (2021)
Luigi Nocera, Mike Wenzel, Claudia Collà Ruvolo, Christoph Würnschimmel, Zhe Tian, Giorgio Gandaglia, Nicola Fossati, Felix K H Chun, Vincenzo Mirone, Markus Graefen, Fred Saad, Shahrokh F Shariat, Francesco Montorsi, Alberto Briganti, Pierre I Karakiewicz
The impact of race/ethnicity on upstaging and/or upgrading rates among intermediate risk prostate cancer patients treated with radical prostatectomy. World journal of urology (2021)
F Abdollah, D Dalela, A Sood, J Sammon, R Cho, Luigi Nocera, M Diaz, Wooju Jeong, J O Peabody, N Fossati, G Gandaglia, A Briganti, F Montorsi, M Menon
Functional outcomes of clinically high-risk prostate cancer patients treated with robot-assisted radical prostatectomy: a multi-institutional analysis. Prostate cancer and prostatic diseases 20 (4) (2017)